BUY WEGOVY PEN UK
BUY WEGOVY PEN UK
Price range: £100.00 through £400.00
Product Details
BUY WEGOVY PEN UK
BUY WEGOVY PEN UK
Wegovy (semaglutide) is a once-weekly prescription injection approved for chronic weight management in adults and adolescents (12+) with obesity or overweight (with comorbidities). It acts as a GLP-1 receptor agonist, reducing hunger to help sustain weight loss alongside diet and exercise. Common side effects include nausea, vomiting, and diarrhea.
Key Details About Wegovy
-
- Indications: Used for weight loss (BMI 30 or 27 with related conditions) and reducing cardiovascular risks (heart attack/stroke).
- Administration: Administered once weekly via subcutaneous injection in the stomach, thigh, or upper arm
.
- Dosage Escalation: To minimize gastrointestinal side effects, the dosage starts at 0.25 mg and increases gradually over 16 weeks to a maintenance dose of 2.4 mg.
-
- Effectiveness: Studies show significant weight reduction, with some users experiencing roughly 15% weight loss.
- Side Effects: Very common side effects include nausea, diarrhea, vomiting, constipation, and abdominal pain.
- Warning: Do not use with other semaglutide or GLP-1 medicines.
Additional information
| Dosage | 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg |
|---|
